This book discusses various biofabrication approaches, processes, and new technologies developed over the years. Technologies covered by the volume include 3D (bio)printing, non-printing manufacturing, hybrid biofabrication, innovations in biomaterials for biofabrication, physicochemical, rheological and mechanical properties of bioinks, translation of physical cues into cellular responses, smart material systems, PRP/PL-based personalized materials, biofabrication strategies for neovascularization, biofabrication with polymers, ceramics and composites, pre-clinical applications for skin, tendons, trachea, bone, skeletal muscle, blood vessels, ocular tissues, 3D-engineered platforms for disease modeling, deep learning, artificial intelligence in biofabrication, and more. It is clear that these approaches will ultimately lead to the development of functional products that may contain living (cells or tissues) and/or non-living (supporting proteins, biomaterials) components. Leading scientists provide insightful perspectives on approaches to this inherently interdisciplinary field, shedding light on future developments and potential new applications.

This is an ideal resource for biomedical and bioengineering researchers working at different stages of development of regenerative medicine tools, including tissue engineering, biomaterials, stem cells, cell therapy and cell banking; scientific administrators and graduate students in biotechnology, cell and molecular biology, materials science and engineering and chemistry fields.

Yaşar Murat Elçin, PhD is a Professor of Biochemistry at Ankara University (AU), Ankara, Türkiye since 1996. He is the founder and head of the “Tissue Engineering, Biomaterials & Nanobiotechnology Laboratory” at AU Faculty of Science, Department of Chemistry, Ankara, Türkiye (www.elcinlab.org). He was the founding Deputy Director of the AU Stem Cell Institute. Prof. Elçin is currently the President of the “Biomaterials & Tissue Engineering Society” (BTES Türkiye). His major research interests are tissue engineering, regenerative biomaterials, and stem cells. He has been involved in the first clinical tissue engineering study in Türkiye (2003). Prof. Elçin is the recipient of major awards, such as the AU Science Award (2008), METU Parlar Science Award (2018), Doktorclub-Biotechnology & Genome Technology Award (2019). He is the inventor of seven patents, founder of a startup company, Biovalda Health Technologies Inc. Prof. Elçin has supervised >55 post-graduate studies. He was the editor of the book “Tissue Engineering, Stem Cells & Gene Therapies” (Plenum Press, 2003). Currently he is the Section Editor of Stem Cell Reviews & Reports [Musculoskeletal Regeneration & Tissue Engineering] (SpringerNature), EB Member of Genes & Diseases (Elsevier), Molecular Biotechnology (Springer), Cell Biology and Translational Medicine [AEMB] (Springer). Prof. Elçin is listed in “Stanford U./Elsevier's World’s High Impact Scientists” Career-Long Impact List (2020, 2021, 2022, 2023, 2024, 2025).